期刊文献+

IL-1Ra和IL-10真核表达质粒载体的构建及其表达检测 被引量:1

Construction and Identification of Eukaryotic Expression Plasmid Encoding Human IL-1Ra and IL-10
下载PDF
导出
摘要 目的:构建人IL-1Ra和人IL-10真核表达质粒载体并检测其表达。方法:用双酶切方法切取PCDI-IL-1Ra和PCDI-IL-10质粒中包含人IL-1Ra和人IL-10 CDS全长序列的cD-NA片段,并分别连接到真核表达质粒pcDNA3.1上,然后用壳聚糖转染上述质粒到原代软骨细胞,RT-PCR检测其mRNA水平的表达。结果:成功将人IL-1Ra和IL-10 CDS全长序列的cDNA片段克隆到真核表达载体,mRNA水平检测到目的基因的表达明显提高。结论:真核表达质粒可以用于外源基因的原代软骨细胞导入和表达,为进一步的基因治疗研究提供依据。 Objective To construct efficient expression plasmid encoding human IL- 1Ra and IL- 10, and provide an important tool for IL- IRa and IL- 10 gene therapy. Methods Plasmid PCDI- IL- 1Ra was treated with endonucleases EcoR Ⅰ and Hind Ⅲ , the the product was ligated with digested vector PcDNA3.1 ( - ) by EcoR Ⅰ and Hind Ⅲ . Plasmid PCDI - IL - 10 was similarly treated with endonucleases BamH Ⅰ and Kpn Ⅰ , and then the product was ligated with digested vector PcDNA3.1 ( + ) by BamH Ⅰ and Kpn Ⅰ . The resultant recombinant plasmids were identified with appropriate endonucleases and sequencing. The transfection efficiency of the constructed plasmids to primary chondrocytes were determined by RT - PCR. Results The human IL- 1Ra and IL- 10 eDNA were certified to be inserted into PcDNA3.1 and its expression in primary chondrocytes improved significantly. Conclusion Cytokines gene can be transfected to primary cells through eukaryotic expression plasmid.
出处 《中国运动医学杂志》 CAS CSCD 北大核心 2006年第1期54-56,100,共4页 Chinese Journal of Sports Medicine
基金 国家体育总局科技攻关重点项目(No.04014)资助
关键词 白介素1受体拮抗剂 白介素10 真核质粒 表达 IL- 1Ra, IL- 10, eukaryotic plasmid, expression
  • 相关文献

参考文献15

  • 1Evans CH,Gouze JN,Gouze E,et al.Osteoarthritis gene therapy.Gene Ther,2004,11(4):379-389.
  • 2Goldring SR,Goldring MB.The role of cytokines in cartilage matrix degeneration in osteoarthritis.Clin Orthop Res,2004,427S:S27-S36.
  • 3Zhang X,Mao Z,Yu C.Suppression of early experimental osteoarthritis by gene transfer of interleukin-1 receptor antagonist and interleukin-10.J Orthop Res,2004,22(4):742-750.
  • 4Huang L,Niidome T.Gene therapy progress and prospects:nonviral vectors.Gene Ther,2002,9:1647-1652.
  • 5Attur MG,Patel IR,Patel RN,et al.Autocrine production of IL-1 beta by human osteoarthritis affected cartilage and differential regulation of endogenous nitric oxide,IL-6,prostaglandin E2,and IL-8.Proc Assoc Am Physicians,1998,110:65-72.
  • 6Melchiorri C,Meliconi R,Frizziero L,et al.Enhanced and coordinated in vivo expression of inflammatory cytokines and nitric oxide synthase by chondrocytes from patients with osteoarthritis.Arthritis Rheum,1998,41:2165-2174.
  • 7Caron JP,Fernandes JC,Martel-pelletier J,et al.Chondroprotective effect of intraarticular injections of interleukin-1receptor antagonist in experimental osteoarthritis.Suppression of collagenase-1 expression.Arthritis Rheum,1996,39:1535-1544.
  • 8Pelletier JP,Caron JP,Evans CH,et al.In vivo suppression of early experimental osteoarthritis by interleukin-1 receptor antagonist using gene therapy.Arthritis Rheum,1997,40:1012-1019.
  • 9Fernandes J,Tardif G,Martel-pellatier J,et al.In vivo transfer of interleukin-1 receptor antagonist gene in osteoarthritic rabbit knee joints:prevention of osteoarthritis progression.Am J Pathol,1999,154:1159-1169.
  • 10Lalanli I,Bhol K,Ahmed AR.Interleukin-10:biology,role in inflammation and auto immunity.Ann Allergy Asthma Immunol,1997,79:468-484.

同被引文献29

  • 1Seed SM,Dunican KC,Lynch AM.Osteoarthritis:a review of treatment options.Geriatrics.2009;64(10):20-29.
  • 2Guccione AA,Felson DT,Anderson JJ,et al.The effects of specific medical conditions on the functional limitations of elders in the Framingham Study.Am J Public Health.1994;84(3):351-358.
  • 3Hunter W.Of the structure and disease of articulating cartilages.1743.Clin Orthop Relat Res.1995;(317):3-6.
  • 4Alcaraz MJ,Megías J,García-Arnandis I,et al.New molecular targets for the treatment of osteoarthritis.Biochem Pharmacol.2010;80(1):13-21.
  • 5Im HJ,Pacione C,Chubinskaya S,et al.Inhibitory effects of insulin-like growth factor-1 and osteogenic protein-1 on fibronectin fragment-and interleukin-1beta-stimulated matrix metalloproteinase-13 expression in human chondrocytes.J Biol Chem.2003;278(28):25386-25394.
  • 6Hsieh JL,Shen PC,Shiau AL,et al.Intraarticular gene transfer of thrombospondin-1 suppresses the disease progression of experimental osteoarthritis.J Orthop Res.2010;28(10):1300-1306.
  • 7Clanchy FI,Williams RO.Plasmid DNA as a safe gene delivery vehicle for treatment of chronic inflammatory disease.Expert Opin Biol Ther.2008;8(10):1507-1519.
  • 8Calich AL,Domiciano DS,Fuller R.Osteoarthritis:can anti-cytokine therapy play a role in treatment? Clin Rheumatol.2010;29(5):451-455.
  • 9Swellam M,Mahmoud MS,Samy N,et al.Potential influence of interleukin-1 receptor antagonist gene polymorphism on knee osteoarthritis risk.Dis Markers.2010;28(5):299-305.
  • 10Fernandes JC,Martel-Pelletier J,Pelletier JP.The role of cytokines in osteoarthritis pathophysiology.Biorheology.2002;39(1-2):237-246.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部